Carbinoxamine Maleate

马来酸卡比沙明

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCarbinoxamine Maleate
Drug Alias Namecarbinoxamina马来酸氯苯吡醇胺马来酸吡氯苄氧胺carbinoxaminum马来酸罗托沙敏 +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H1 receptor antagonists
TargetsHistamine H1 receptor
Therapy Area/IndicationsHypersensitivityUrticariaConjunctivitis, Allergic +[4] 
Global Approved IndicationsHypersensitivity
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1953/01/01
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesTris Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesAytu Bioscience IncAvalo Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsHypersensitivityUrticariaConjunctivitis, Allergic +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeR06AA08
Related LinksWikipediaDrugBankKEGG